Method for evaluating killing effect through co-culture of CAR-T cells and pancreatic cancer organoid
Through the co-culture method of CAR-T cells and pancreatic cancer organoids, the problem that traditional two-dimensional cell culture is difficult to simulate the immune response in vivo is solved, and qualitative and quantitative evaluation of the killing effect of T cells is achieved, and new tumor immunotherapy is provided Models and drug development methods.
Patent Information
- Application Number
- CN202411241207.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-05
- Publication Date
- 2024-11-26
AI Technical Summary
Traditional two-dimensional cell culture has limitations, making it difficult to effectively simulate in vivo immune responses, and lacks individualized in vitro models to verify the efficacy of tumor immunotherapy.
Through the co-culture method of CAR-T cells and pancreatic cancer organoids, TryplE digestive enzyme is used for digestion and passage. After suspension culture, CAR-T cells and pancreatic cancer organoids are mixed in a specific proportion and co-cultured in a specific culture medium. Annexin is used V-FITC/PI staining and CellToxTMGreen Cytotoxicity Assay were performed qualitative and quantitative analysis to evaluate the killing effect of CAR-T cells on tumor organoids.
An in vitro platform has been built that can effectively evaluate the potential killing ability of T cells in the body, and provides new tumor immunotherapy models and means to help explore new therapeutic strategies and drug development methods.
Smart Images

Figure CN119020448A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of tumor immunotherapy, and specifically to a method for evaluating the killing effect of CAR-T cells and pancreatic cancer organoids through co-culturing. Background Art
[0002] In recent years, tumor immunotherapy has been very popular in cancer treatment. The purpose of tumor immunotherapy is to stimulate or mobilize the body's immune system and enhance the anti-tumor immunity of the tumor microenvironment, thereby controlling and killing tumor cells. The rise of immunotherapy has also promoted the development of tumor research, but due to the complexity of the humanized system, partial or ineffective reconstruction of the immune system and other problems, immune tumor models face huge challenges. In clinical practice, there is an urgent need for in vitro models that can be used for individualized verification of efficacy.
[0003] However, traditional two-dimensional cell culture has various limitations, while the new organoids have initially possessed the complex cellular microenvironment of the tissue of origin, and are highly similar to the source tissue or organ in vivo in terms of genome and molecular markers. The co-culture environment of organoids and immune cells increases the environmental stimulation of immune cell infiltration in the in vitro culture of organoids, which is closer to the in vivo growth environment, providing an ideal experimental platform for the study of autoimmune diseases, tumors and related immunotherapies. Therefore, the construction of a co-culture system of organoids and immune cells has broad application prospects in disease research, drug development and tumor immunotherapy. Summary of the invention
[0004] In view of this, one of the purposes of the present invention is to provide a method for co-culturing CAR-T cells and pancreatic cancer organoids to evaluate the killing effect; through the co-culture of organoids and immune cells, it is helpful to have a deeper understanding of the occurrence and development of the disease, explore new treatment strategies and drug development methods, provide new models and means for cancer immunotherapy, and provide strong support for personalized tumor treatment.
[0005] In order to achieve the above object, the present invention provides the following technical solutions:
[0006] 1. The method for evaluating the killing effect of CAR-T cells and pancreatic cancer organoids by co-culture is to digest and passage the pancreatic cancer organoids with TryplE digestive enzyme, culture them in suspension overnight, and then mix the CAR-T cells with pancreatic cancer organoids at an effector-target ratio of 50:1 to 100:1, and then add co-culture medium for at least 4 hours, and observe the complete morphology of the organoids by Annexin V-FITC / PI staining or use CellTox TM Green Cytotoxicity Assay was used to quantitatively detect and analyze the killing effect.
[0007] T cells are the main immune cells in tumor immunity. Pancreatic cancer organoids are co-cultured with activated peripheral blood T cells (CAR-T cells) to establish a model, and the effect of tumor organoids being killed by CAR-T cells is qualitatively and quantitatively evaluated, thereby building an in vitro evaluation platform that can evaluate the potential killing ability of T cells in vivo.
[0008] Preferably, the co-culture medium uses pancreatic cancer organoid culture medium as a mother solution, to which IL2 and matrigel are added, so that the final concentration of IL2 is 200 IU / ml and the volume fraction of matrigel is 5%.
[0009] The mass ratios of the components of the pancreatic cancer organoid culture medium are as follows: 10mM HEPES, 1% Glutamax, 100μg / ml Primocin, 1% Penicillin-Streptomycin, 500nM A83-01, 1% B27 supplement, 10μM Y-27632, 1.56mM N-acetylcysteine, 10mM Nicotinamide, 10ng / ml FGF10, 10μM forskolin, 300ng / ml Wnt-3A, 500ng / ml R-spondin1, 30ng / ml Noggin, and the rest is the basic culture medium Advanced DMEM-F12.
[0010] Preferably, the culture medium used for CAR-T cell culture of the present invention is: 10% inactivated FBS, 1% penicillin-streptomycin, 1% sodium pyruvate, 1% non-essential amino acids, 200 IU / ml IL2, and the remainder is the basal culture medium RPMI 1640.
[0011] Preferably, the Annexin V-FITC / PI staining is performed by diluting the Annexin V-FITC and PI working solutions with DPBS at a volume ratio of Annexin V-FITC:DPBS of 1:10 and a volume ratio of PI:DPBS of 1:8.
[0012] Preferably, the CellTox TM Green Cytotoxicity Assay is a quantitative detection analysis of CellTox TM After the Green Cytotoxicity Assay Kit is thawed, take the Assay Buffer and CellTox TM GreenDye was mixed at a volume ratio of 200:1 to prepare an apoptosis detection working solution, which was then added to the detection wells and incubated at room temperature in the dark for 15 min. The fluorescence intensity at Ex / Em=490 / 525 nm was detected by an ELISA reader.
[0013] The beneficial effects of the present invention are as follows: the present invention discloses a method for evaluating the killing effect of CAR-T cells and pancreatic cancer organoids by co-culturing them. The co-culturing of organoids and immune cells helps to gain a deeper understanding of the occurrence and development of the disease, explore new treatment strategies and drug development methods, and provide new models and means for cancer immunotherapy. By qualitatively and quantitatively evaluating the killing effect of tumor organoids by CAR-T cells, an evaluation platform is established in vitro that can evaluate the potential killing ability of T cells in vivo. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] In order to make the purpose, technical solution and beneficial effects of the present invention clearer, the present invention provides the following drawings for illustration:
[0015] Figure 1 The recruitment of CAR-T cells by tumor organoids (A: pancreatic cancer organoid blank control group, indicating that the culture system can well maintain the morphological characteristics of pancreatic cancer organoids; B and C: CAR-T cells and pancreatic cancer organoid co-culture experimental groups, indicating that CAR-T cells can gather around pancreatic cancer organoids and form recruitment and infiltration phenomena; A and B were taken under ordinary light microscopy under a 10x objective, and C was taken under ordinary light microscopy under a 20x objective).
[0016] Figure 2 This is a qualitative analysis of the killing of tumor organoids by CAR-T cells. The results showed that compared with the control group, the proportion of dead cells in the CAR-T group organoids increased significantly, and the organoids lost their complete morphology and were in a disintegrated state, indicating that CAR T cells have a killing effect on organoids;
[0017] Figure 3 Quantitative analysis of CAR-T cell killing of tumor organoids (A and B are two different pancreatic cancer organoid samples. It can be seen that the cell apoptosis fluorescence signals of the two CAR-T cell experimental groups are significantly higher than those of Organoids only and Cells; and as the effector-target ratio increased, the apoptosis fluorescence signal showed an upward trend, indicating that the killing effect on pancreatic cancer organoids was gradually enhanced). DETAILED DESCRIPTION
[0018] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.
[0019] Example 1. Establishment of a co-culture system of CAR-T cells and pancreatic cancer organoids
[0020] A pancreatic cancer organoid culture medium, wherein the final concentration of each component is as follows: 10mM HEPES, 1%
[0021] Glutamax, 100μg / ml Primocin, 1% Penicillin-Streptomycin, 500nM A83-01, 1% B27supplement, 10μM Y-27632, 1.56mM N-acetylcysteine, 10mM Nicotinamide, 10ng / mlFGF10, 10μM forskolin, 300ng / ml Wnt-3A, 500ng / ml R-spondin1, 30ng / ml Noggin, and the rest was basal medium Advanced DMEM-F12.
[0022] A CAR-T cell culture medium, having the following formula: 10% inactivated FBS, 1% penicillin-streptomycin, 1% sodium pyruvate, 1% NEAA (brand: Thermo, catalog number: 11140050), 200 IU / ml IL2, and the balance being a basic culture medium RPMI 1640;
[0023] A culture medium for co-culturing CAR-T cells and pancreatic cancer organoids, wherein the culture medium is based on pancreatic cancer organoid culture medium as a mother solution, to which 200 IU / ml IL2 and matrix gel are added, wherein the volume proportion of the matrix gel is 5%.
[0024] Example 2. Establishment of a co-culture method of CAR-T cells and pancreatic cancer organoids
[0025] (1) Organoid suspension culture: Pancreatic cancer organoids in a 6-well plate were digested using TryplE digestive enzyme, and the digested organoids were suspended and cultured overnight in a low-adhesion 6-well plate.
[0026] (2) Organoid counting
[0027] a. Mix the tumor organoids (about 80 μm in diameter) that were cultured in suspension (ultra-low adsorption 6-well plate culture) one day in advance by pipetting, aspirate 10 μL and count under a microscope (if the number of organoids is large, they should be diluted 10 times / 100 times before counting), and calculate the organoid concentration (organoids / ml).
[0028] b. Centrifuge the collected tumor organoids at 4°C and 400g for 5 min to obtain the organoid precipitate.
[0029] (3) CAR-T cell count
[0030] a. Collect the cultured CAR-T cells into a 15 mL centrifuge tube, pipette and mix to form single cells, aspirate 10 μL and count using an automatic cell counter (if the number of CAR-T cells is large, dilute 10 times / 100 times before counting), and record the density of live cells (cells / ml).
[0031] b. The collected CAR-T cells were centrifuged at 4°C, 400g for 5 min to obtain cell pellets.
[0032] (4) CAR-T cell staining
[0033] a. Resuspend the cell pellet obtained in step (3) in DPBS and centrifuge at 400 g for 5 min at 4°C.
[0034] b. Staining: discard the supernatant, add FDA working solution (the stock solution was diluted with DPBS 1:1000) to the CAR-T cell pellet, add 500 μL to a 1.5 mL EP tube, pipette to mix, and incubate in a cell culture incubator at 37°C and 5% CO2 for 30 min.
[0035] c. Washing: After incubation, CAR-T cells were centrifuged at 4°C, 400g for 5 min, and the supernatant was discarded. DPBS was added for washing twice, and the supernatant was discarded after centrifugation at 400g.
[0036] (5) Co-culture of CAR-T cells and organoids
[0037] a. Resuspension: Calculate the number of CAR-T cells and organoids required according to the experimental grouping, which are 2.16e6 and 9600 cells, respectively. Calculate the volume of co-culture medium for resuspension according to the cell and organoid densities recorded in (2) and (3), and use this volume of co-culture medium to resuspend the CAR-T cells and organoid pellets for later use.
[0038] b. Inoculation: Set the effector-target ratio of CAR-T cells to organoids to 50:1 and 100:1, respectively. Calculate the volume of CAR-T cell suspension and organoid suspension added to each well based on the effector-target ratio, and then use co-culture medium to make up to 100 μL system.
[0039] Observe the cells in co-culture, the results are as follows Figure 1 The results showed that CAR-T cells were able to gather around pancreatic cancer organoids, forming recruitment and infiltration phenomena.
[0040] Example 3: Qualitative analysis of CAR-T cell killing of pancreatic cancer organoids
[0041] (1) Annexin V-FITC and PI staining: Prepare Annexin V-FITC and PI 10X working solution (Annexin V-FITC 1:10, PI 1:8, diluted in DPBS), add 11 μL of Annexin V-FITC and PI 10X working solution to each well.
[0042] (2) Incubate in a cell culture incubator at 37°C and 5% CO2 for 30 min.
[0043] (3) Photography: Observe the killing of tumor organoids by CAR-T cells using an inverted fluorescence microscope and take photos.
[0044] Then the casualties were counted, and the results were as follows: Figure 2 The results showed that as the effector-target ratio of the CAR-T cell experimental group increased, CellTox TM The activity of Green showed an increasing trend, indicating that the killing effect on pancreatic cancer organoids was gradually enhanced, and the killing effect was higher than that of the control group.
[0045] Example 4: Quantitative analysis of CAR-T cell killing of pancreatic cancer organoids
[0046] (1) CAR-T cells were co-cultured with tumor organoids for 4 h, 20 h, 28 h, and 44 h (the specific detection time point can be set according to experimental requirements) to detect the apoptosis of tumor organoids.
[0047] (2) CellTox TM All components of the Green Cytotoxicity Assay Kit were completely thawed in a 37°C water bath. To ensure thorough mixing, vortex the following components: CellTox TM Green Dye, Assay Buffer and Lysis Solution. If the amount of liquid in the tube is small, you may need to centrifuge briefly to allow the liquid to accumulate at the bottom of the tube.
[0048] (3) Estimate the required CellTox based on experimental requirements TM Green Reagent 5X Concentrate. Transfer Assay Buffer to a new centrifuge tube in multiples of 2 ml. Add 10 μl CellTox to every 2 ml Assay Buffer. TM Green Dye (1:200 dilution). Mix the Assay Buffer and CellTox TM Vortex Green Dye to mix thoroughly and prepare the apoptosis detection working solution.
[0049] (4) 15 minutes before each detection time point, add 100 μL of apoptosis detection working solution to the sample well to be detected and incubate at room temperature in the dark for 15 minutes.
[0050] (5) The fluorescence intensity at Ex / Em=490 / 525 nm was detected by Biotec Cytation5 microplate reader. The results are as follows Figure 3 As shown in Figure 2, the qualitative analysis of Annexin V-FITC / PI staining showed that Compared with the cell group and T cell blank group, the proportion of dead cells in the CART group increased significantly, and the organoids lost their complete morphology and collapsed, indicating that CART cells have a killing effect on organoids. Save and record the test data, and use Graphpad Prism software to draw a killing curve (such as Figure 3 (as shown in A and B).
[0051] Comparative Example
[0052] This example is a negative control group. There are two negative control groups, one of which is The cell group (unactivated T cells) had an effector-target ratio of 100:1, and the other group was a T cell blank group. The co-culture system was the same as in Example 2, the qualitative analysis method was the same as in Example 3, and the quantitative analysis method was the same as in Example 4.
[0053] The above-described embodiments are only preferred embodiments for fully illustrating the present invention, and the protection scope of the present invention is not limited thereto. Equivalent substitutions or changes made by those skilled in the art based on the present invention are within the protection scope of the present invention. The protection scope of the present invention shall be subject to the claims.
Claims
1. A method for evaluating the killing effect of CAR-T cells and pancreatic cancer organoids by co-culturing, characterized in that: Pancreatic cancer organoids were digested and passaged with TryplE digestive enzymes. After passage, they were cultured in suspension overnight. Then, CAR-T cells were mixed with pancreatic cancer organoids at an effector-target ratio of 50:1 to 100:
1. Then, co-culture medium was added and co-cultured for at least 4 hours. The complete morphology of the organoids was observed by Annexin V-FITC / PI staining or CellTox was used. TM Green Cytotoxicity Assay was used to quantitatively detect and analyze the killing effect.
2. The method for evaluating the killing effect of CAR-T cells and pancreatic cancer organoids by co-culturing according to claim 1, characterized in that: The co-culture medium uses pancreatic cancer organoid culture medium as the mother liquid, and IL2 and matrigel are added to the medium, so that the final concentration of IL2 is 200 IU / ml, and the volume fraction of matrigel is 5%; The mass ratios of the components of the pancreatic cancer organoid culture medium are as follows: 10mM HEPES, 1% Glutamax, 100μg / ml Primocin, 1% Penicillin-Streptomycin, 500nM A83-01, 1% B27 supplement, 10μM Y-27632, 1.56mN-acetylcysteine, 10mM Nicotinamide, 10ng / ml FGF10, 10μM forskolin, 300ng / ml Wnt-3A, 500ng / ml R-spondin1, 30ng / ml Noggin, and the rest are the basic culture medium Advanced DMEM-F12.
3. The method for evaluating the killing effect of CAR-T cells and pancreatic cancer organoids by co-culturing according to claim 1, characterized in that: The culture medium used for CAR-T cell culture is: 10% inactivated FBS, 1% penicillin-streptomycin, 1% sodium pyruvate, 1% non-essential amino acids, 200 IU / ml IL2, and the remainder is the basic culture medium RPMI 1640.
4. The method for evaluating the killing effect of CAR-T cells and pancreatic cancer organoids by co-culturing according to claim 1, characterized in that: The Annexin V-FITC / PI staining is performed by diluting the Annexin V-FITC and PI working solutions with DPBS at a volume ratio of Annexin V-FITC:DPBS of 1:10 and a volume ratio of PI:DPBS of 1:
8.
5. The method for evaluating the killing effect of CAR-T cells and pancreatic cancer organoids by co-culturing according to claim 1, characterized in that: The CellTox TM Green Cytotoxicity Assay is a quantitative detection analysis of CellTox TM After the GreenCytotoxicity Assay Kit is thawed, take the Assay Buffer and CellTox TM The apoptosis detection working solution was prepared by mixing Green Dye at a volume ratio of 200:1, and then added to the detection wells. The mixture was incubated at room temperature in the dark for 15 min, and the fluorescence intensity at Ex / Em=490 / 525 nm was detected by an enzyme marker.
Citation Information
Cited By
Construction method and application of gastric cancer treatment effect evaluation model of CAR-T cells
CN119899805A
